Abstract-Adipose tissue dysfunction related to obesity is overwhelmingly associated with increased risk of developing cardiovascular diseases. In the setting of obesity, (pro)renin receptor (PRR) is increased in adipose tissue of mice. We sought to determine the physiological consequences of adipocyte-PRR deficiency using adiponectin-Cre mice. We report a unique model of adipocyte-PRR-deficient mice (PRR Adi/Y ) with almost no detectable white adipose tissues. As a consequence, the livers of PRR Adi/Y mice were enlarged and demonstrated a marked accumulation of lipids. Adipocytespecific deficiency of PRR increased systolic blood pressure and the concentration of soluble PRR in plasma. To determine whether adipocyte-PRR was involved in the development of obesity-induced hypertension, mice were fed a low-fat or a high-fat diet for 16 weeks. Adipocyte-PRR-deficient mice were resistant to diet-induced obesity. Both high-fat-and low-fat-fed PRR Adi/Y mice had elevated insulin levels. Interestingly, adipocyte-PRR deficiency improved glucose tolerance in high-fat-fed PRR Adi/Y mice. In response to feeding either low-fat or high-fat diets, systolic blood pressure was greater in PRR Adi/Y mice than in control mice. High-fat feeding elevated soluble PRR concentration in control and PRR Adi/Y mice. In vitro knockdown of PRR by siRNA significantly decreased mRNA abundance of PPARγ (peroxisome proliferator-activated receptor gamma), suggesting an important role for PRR in adipogenesis. Our data indicate that adipocyte-PRR is involved in lipid homeostasis and glucose and insulin homeostasis, and that soluble PRR may be a predictor of metabolic disturbances and play a role in systolic blood pressure regulation. 
H ypertension is the major cause of cardiovascular diseases worldwide and, according to the National Health and Nutrition Examination Survey III (NHANES III), the prevalence of hypertension continues to increase. 1, 2 Obesity is an important risk factor for hypertension. 1 The renin angiotensin system (RAS) is recognized for playing a critical role in the regulation of blood pressure and sodium and water homeostasis. The deletion of components of the RAS, for instance angiotensinogen in liver or adipose tissue, prevents obesityrelated hypertension. 3, 4 Among the components of the RAS expressed in adipose tissue, 5, 6 (pro)renin receptor (PRR) is abundant and is upregulated during the development of obesity. 3, [7] [8] [9] PRR is a 350-amino acid protein with a single transmembrane domain and has been first identified as the receptor for renin in its active form and for prorenin in its inactive form. 10, 11 Treatment of preadipocytes, extracted from adipose tissue, with angiotensinogen and renin results in a dose-dependent increase in angiotensin I (AngI) generation. Specific deletion of PRR in the brain attenuates angiotensin II-dependent hypertension, whereas human PRR transgenic rats exhibit elevated systolic blood pressure. 12, 13 Taken together, these results suggest that adipose PRR may potentially play a role in blood pressure control. 7, 11 In addition, PRR can be cleaved intracellularly by furin, resulting in the secretion of a soluble form of PRR (sPRR) in plasma 14 and urine, 15, 16 which might bind renin and prorenin 15 and participate in AngI formation. [14] [15] [16] [17] Previous studies have shown that increased plasma sPRR levels in early pregnancy are associated with the development of preeclampsia, 18 a hypertension-related complication. Conversely, lower plasma sPRR levels were observed in patients treated with angiotensin II receptor blockers. 19 The physiological consequences of changes in plasma sPRR levels during the development of obesity and hypertension remain unclear.
The function of PRR is not restricted to AngI generation and hypertension. The binding of renin or prorenin to PRR
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in mesangial cells 11 and 3T3-L1 preadipocytes 7, 8 initiates an intracellular signaling cascade associated with the activation of the extracellular signal-regulated kinase (ERK) 1/2 pathway. In mesangial cells, the activation of the ERK1/2 pathway leads to the release of transforming growth factor-β1 and cytokines involved in inflammation. However, past attempts to generate complete PRR knockout mice failed. 20 Specific cardiomyocyte or podocyte deletion of PRR led to animal lethality 3 weeks after birth caused by heart or kidney failure. [21] [22] [23] [24] Because PRR interacts with V-ATPase, the deletion of PRR may trigger destabilization of V-ATPase activity, leading to a decrease in vacuolar acidification and to the lethality of cells. [21] [22] [23] [24] In addition, recent studies in xenopus have shown that PRR may link V-ATPase to the Wnt receptor protein, LRP6, and induce phosphorylation of LRP6. 25, 26 The objectives of our study were to determine (1) whether a specific adipocyte-PRR deficiency mouse model is viable, (2) the physiological consequences of adipocyte-PRR deletion on blood pressure in normal physiology and during the development of obesity, and (3) the relationship between adipocyte-PRR, plasma sPRR concentrations, the RAS, and blood pressure.
Methods and Animals
All procedures involving animals were conducted in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory ) expressing Cre recombinase under the control of the adiponectin promoter (Strain Name: B6;FVB-Tg(Adipoq-cre)1Evdr/ JB6;FVB-Tg(Adipoq-cre)1Evdr/J) 24 ( Figure 1A ). Diets, plasma measurements, histology, radiotelemetry, and statistical analyses are described in the online-only Data Supplement.
Statistical Analysis
Results are expressed as mean±SEM. All data were analyzed using Sigma Plot and Graph Prism. ANOVAs (and ANOVA repeated measures when appropriate) were used to compare diet and genotype effects, followed by post hoc tests using Holm-Sidak or Bonferroni corrections for multiple comparisons. When the assumptions underlying the ANOVAs were not otherwise met, data were nonlinearly transformed; however, for ease of illustration, figures show untransformed data. GraphPad QuickCalcs (Grubbs test) was used to determine statistical outliers, and a t test was used to compare mean insulin levels between high-fat (HF)-and low-fat (LF)-fed mice. Statistical significance was defined as P<0.05.
Results

Generation of Mice With Adipocyte-PRR Deficiency
To confirm efficiency of PRR deletion in adipocytes, preadipocytes from the stromal vascular fraction of subcutaneous adipose tissue of control mice (PRR 
Adipocyte Deficiency of PRR Drastically Decreased Adipose Tissue Mass in Male Mice Fed a Standard Diet
Body weight increased with age ( Figure 2A) mice showed an unexpectedly small number of differentiated adipocytes ( Figure S2 ). To determine whether adipocyte-PRR was involved in adipocyte differentiation, PRR was silenced in vitro in 3T3-L1-cells ( Figure S3 ). Peroxisome proliferator-activated receptor gamma (PPARγ), an important gene involved in adipocyte differentiation, and fatty acid-binding protein 4 (Fabp4 or aP2), a marker for differentiated adipocytes and a carrier protein for fatty acids, were evaluated. The abundance of mRNA PPARγ and Fabp4 was significantly decreased in differentiated siPRR cells compared with control cells. (Table S1 ). Glucose tolerance did not differ between genotypes at week 5, 9, or 13 of the experiment ( Figure S4 ). (Table S1 ).
Adipocyte-Specific
Adipocyte-Specific Deficiency of PRR Increased Systolic Blood Pressure of Male Mice Fed a Standard Diet
The SBP and the pulse pressure were significantly higher in PRR Adi/Y mice than in PRR fl/Y mice ( Figure 3 ). Mean arterial blood pressure, diastolic blood pressure, and heart rate did not differ significantly between groups (Table S2) .
Adipocyte-Specific Deficiency of PRR Increased Plasma sPRR Concentrations
Adipocyte-specific deficiency of PRR did not change plasma angiotensinogen concentration ( Figure 4A ). Plasma renin activity and plasma renin concentration did not differ significantly (Table S3) . Adipocyte-PRR deficiency did not Figure S9C ). Adipocyte-PRR deficiency induced a significant increase in plasma insulin levels regardless of diet (Table S3) .
Despite the Resistance to HF-Diet-Induced Obesity, Adipocyte-Specific Deficiency of PRR Further Increased SBP
Adipocyte-specific deficiency of PRR induced a significant increase in SBP in LF-fed mice ( Figure 6 ). The increase in SBP, resulting from PRR deficiency, was further exacerbated when PRR Adi/Y mice were fed a HF diet. These data suggest that adipocyte-specific deficiency of PRR aggravated HF-diet-induced elevation of SBP. Mean arterial pressure and heart rate were higher in PRR Adi/Y mice regardless of diet (Table S4 and S5). 
In Obese Mice, Adipocyte-Specific Deficiency of PRR Exaggerated the Elevation of Plasma sPRR Levels
Discussion
This study examined the role of adipocyte-derived PRR in blood pressure control and the physiological consequences of the deletion of PRR in adipocytes of male mice during the development of obesity. The deletion of adipocyte-PRR induced a marked reduction in all white adipose tissues with no abnormal distribution of adipose tissue pads. In vitro studies demonstrated that PRR regulated PPARγ and Fabp4. The lipodystrophy was accompanied by hepatic steatosis. When challenged with HF feeding, adipose PRR-deficient mice were resistant to the development of obesity and had improved glucose tolerance. Despite the absence of white adipose tissue and the resistance to diet-induced obesity, mice with adipocyte-PRR deficiency had elevated blood pressure. This blood pressure elevation in adipocyte-PRR-deficient mice seemed to be independent of systemic angiotensinogen and renin concentrations. Surprisingly, plasma sPRR concentrations were increased with HF diet and markedly elevated in adipocyte-PRR-deficient mice. Deletion of adipocyte-PRR led to a reduction of adipose tissue mass and an increase in lipid deposition in liver, suggesting lipodystrophy accompanied by liver steatosis. In vitro PRR silencing revealed a significantly decrease of PPARγ and Fabp4, suggesting that PRR is a master regulator of adipocytes differentiation. In addition, because fatty acid-binding proteins are important carriers for fatty acids uptake and fatty acids transport to sites of esterification into triglycerides, 27 our data suggest an important role of PRR in fatty acid trafficking and storage in adipocytes.
Our phenotype has been observed in other models of lipodystrophy such as the A-ZIP/F, aP2/DTA, SREBP-1c, or fatty liver dystrophy transgenic mouse models. 28 which had improved ability to respond to acute glucose overload compared with controls when challenged with HF feeding. As suggested by Tsai et al, 30 the expansion of pancreatic islets likely could contribute to this increased responsiveness to glucose. Similar to our model, CGI-58β mouse 31 model developed hepatic steatosis but were protected against obesity and glucose intolerance. A reduction of body weight may also have contributed to better glucose sensitivity.
PRR Adi/Y mice exhibited elevated blood pressure similar to that reported in PPARγ P465L/+ mice and humans expressing FPLD2 and FPLD3 mutations. [28] [29] [30] In the latter instances, the cause of increased blood pressure is not well understood. Elevated leptin has been associated with elevated blood pressure 32 but could protect against nonalcoholic fatty liver disease. 33 Thus, although it is unlikely that low levels of circulating leptin in PRR Adi/Y mice could have contributed to elevated blood pressure, low levels of circulating leptin may have contributed to the development of liver steatosis.
Insulin resistance can cause increased blood pressure, thus elevated insulin levels could have participate to the elevation of SBP in PRR Adi/Y mice. 28 However, our results demonstrated that insulin levels were not correlated with SBP suggesting that elevated insulin might not be the origin of elevated blood pressure. In contrast, we have demonstrated that plasma sPRR levels increased with the development of obesity-induced hypertension. Surprisingly, the elevation of plasma sPRR concentrations was exacerbated by adipocyte-PRR deficiency. The elevation of plasma sPRR concentration during early pregnancy has been reported to predict both hypertension and preeclampsia risk in pregnant woman. 18 Moreover, patients with heart failure have higher plasma sPRR levels than control subjects. 34 However, our demonstration of a positive correlation between sPRR and SBP when control mice and PRR Adi/Y mice are combined or in control mice only suggests that sPRR could play a role in blood pressure control. Further investigation are needed about a direct effect of sPRR on SBP. The heart, brain, liver, kidney, and smooth muscle express PRR gene and could potentially participate to the release of sPRR or be potential target tissues. [13] [14] [15] [16] [17] [18] 34 Adipose tissue is one source of systemic angiotensin II, and both expansion and reduction of adipose tissue activate adipose RAS, thereby influencing blood pressure regulation. 3, 4, 30, 35, 36 Because Tsai et al 30 demonstrated that the expression of angiotensinogen and AT1R in adipose tissue is increased in In PRR Adi/Y mice, the reduction of adipose tissue weight in conjunction with elevated plasma angiotensinogen may have activated local adipose RAS. Unfortunately, due to the severe reduction in adipose tissue, we lacked sufficient adipose tissue weight to confirm this hypothesis. Hepatocyte angiotensinogen deficiency induced profound reductions in blood pressure, systemic angiotensinogen, and angiotensin II, which influences adipose RAS content and secretion despite the continued presence of obesity. 4 Because the liver is an important source of renal angiotensin II, 37 it may also be possible that other local RAS are activated to compensate for the absence of adipose tissue. In contrast to liver angiotensinogen deficiency, PRR Adi/Y mice demonstrated a radical shift in lipid distribution resulting in hepatic steatosis, which might also have influenced adipose and other local RAS systems. 38 Indeed, despite lower body weights and adipose tissue weights in PRR Adi/Y mice, systemic angiotensinogen concentrations were not lower than those of obese control mice, suggesting substantial compensatory activation of systemic angiotensinogen from other tissues.
Perspectives
The remarkable phenotype of the adipocyte-PRR-deficient mouse model demonstrates the importance of adipocyte-PRR in lipid and glucose and insulin homeostasis. Our results demonstrate the necessity of adipocyte-PRR in the normal development of adipose tissue, beyond its potential role in local RAS activation. Further investigation is needed to determine the mechanism by which PRR regulates adipose cell formation and lipid homeostasis and blood pressure.
What Is New?
• Demonstration that adipocyte-derived (pro)renin receptor (PRR) deficiency regulates fat mass growth.
• Demonstration that adipocyte-derived PRR influences lipid homeostasis and glucose and insulin homeostasis.
• Demonstration that adipocyte-derived PRR deficiency increases plasma soluble PRR and blood pressure.
What Is Relevant?
• This study demonstrates that adipocyte-PRR is essential for the development of adipose tissue.
• This study demonstrates that adipocyte-PRR contributes to the control of blood pressure.
Summary
The effect of PRR to reduce fat mass is profound in mice with dietinduced obesity, demonstrating the important role of PRR in fat mass growth. Adipose PRR-deficient mice show elevated plasma insulin. In obese mice, adipocyte-PRR deficiency improves glucose tolerance. adipocyte-PRR deficiency elevates SBP and increases plasma soluble PRR levels. Figure 1A) . 24 Experimental protocol Characterization of the model: Male PRR Adi/Y mice (n= 4) and PRR fl/Y mice (n= 6) 2 months of age were fed a standard laboratory diet (18% protein, Global Diet; Teklad Harlan Madison, WI) for 16 weeks. Mice were provided water and diet ad libitum. Fat, lean and water mass were measured monthly on conscious mice using NMR spectroscopy (Echo MRI, Houston, TX). Diet-induced obesity study: Male PRR Adi/Y mice (n=13) and PRR fl/Y control mice (n=13) (2 months of age) were randomly assigned to low-fat (LF) (10% of total calories as fat; catalog #D12450J) or high-fat (HF) (60% total calories as fat; catalog #D12492) diets from Research Diets Inc (New Brunswick, NJ) for 16 weeks. Mice were provided water and diet ad libitum. At study endpoint, mice were anesthetized with a mixture of ketamine/xylazine (100/10 mg/kg, i.p) and exsanguinated. Blood was collected in tubes (4ºC) containing EDTA (0.2 mol/L), centrifuged at 5,000 rpm for 10 min, and plasma was stored at -80°C. Tissue was harvested, snap frozen in liquid nitrogen, and stored at -80°C.
Methods
Animals
Quantification of glucose tolerance
Intraperitoneal glucose tolerance tests were performed monthly as previously described. 1 Blood glucose concentrations were quantified with a hand-held glucometer before (0 min) and after (15, 30, 60 and 120 min) glucose administration (1 mg/kg body weight, i.p).
Quantification of plasma components
Determination of plasma renin activity (PRA). Plasma (8 µL) was incubated at 37ºC (30 min) in phosphate buffer containing EDTA (0.05 mol/L) and enalapril (10 µmol/L). The angiotensin I generated was then quantified by radioimmunoassay as described previously. 1 Determination of plasma renin concentrations (PRC). Plasma (8 µL) was incubated at 37ºC (30 min) with exogenous AGT (25 nmol/L; generated from nephrectomized rats) followed by quantification of angiotensin I by radioimmunoassay. Quantification of plasma AGT. Plasma (10 µL) concentrations of AGT were quantified using a mouse total AGT assay kit (Immuno-Biological Laboratories Co, Minneapolis, MN). Quantification of plasma sPRR. Plasma (10 µL) concentrations of sPRR were quantified using a soluble (Pro)renin Receptor ELISA kit (Immuno-Biological Laboratories Co, Minneapolis, MN). Quantification of plasma cholesterol and triglycerides were assessed by using a Wako kit (Wako Chemicals, Richmond, VA), plasma insulin using ultra-sensitive mouse insulin ELISA kit (Crystal Chem Inc, Downers Grove, IL), plasma mouse prorenin+renin total using a mouse prorenin/renin total antigen ELISA kit (Molecular innovation, Novi, MI), leptin plasma using a Mouse Leptin ELISA kit (Millipore, Billerica, MA), and plasma of C-Reactive protein using a mouse CReactive protein antigen ELISA kit (Molecular innovation, Novi, MI). Quantification of blood pressure by radiotelemetry After 15 weeks of diets, mice were anesthetized with isoflurane and implanted with a carotid artery catheter connected to a telemetry device (model PA-C10). After recovery (range, 7-10 days), mean arterial, systolic and diastolic blood pressure, pulse pressure and locomotor activity were recorded continuously for 5 days. Blood pressure was quantified as described previously. 1 Kidney, adipose tissue and liver immunostaining Kidney were fixed with formalin and embedded in paraffin and processed through paraffin. Sections (4 µm) were stained for Masson's trichrome (Sigma, St. Louis, MO) and visualized at 40x magnification using a Nikon Eclipse 80i light microscope and Nikon NIS-elements visualization software. 40x fields (9 to 32 fields per animal) were captured and collagen content was quantified using NIH imageJ software. For adipose tissue, gonadal adipose tissues were fixed with formalin and embedded in paraffin and processed through paraffin. Sections were stained with hematoxylin and eosin. Sections of adipose tissue from each mouse were photographed under 10X magnification. Livers were collected, fixed in paraformaldehyde and embedded in paraffin blocks. Sections were stained with hematoxylin and eosin and examined by light microscopy. For neutral lipids analysis, liver sections were stained with Oil Red O and quantified using NIS Elements BR. 
Statistical analysis
Results are expressed as mean±SEM. All data were analyzed using Sigma Plot and Graph Prism. ANOVAs (and ANOVA repeated measures when appropriate) were used to compare diet and genotype effects, followed by post-hoc tests using Holm-Sidak or Bonferroni corrections for multiple comparisons. When the assumptions underlying the ANOVAs were not otherwise met, data were nonlinearly transformed; however, for ease of illustration, figures show untransformed data. GraphPad QuickCalcs (Grubbs' test) was used to determine statistical outliers and a t-test was used to compare mean insulin levels between HF-and LF-fed mice. Statistical significance was defined as P<0.05. 
